Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study

INTRODUCTION: There is limited information published on switching erythropoiesis-stimulating agent (ESA) treatment for anemia associated with chronic kidney disease (CKD) from darbepoetin alfa (DA) to methoxy polyethylene glycol-epoetin beta (PEG-Epo) outside the protocol of interventional clinical...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Choi, Peter, Farouk, Mourad, Manamley, Nick, Addison, Janet
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898130/
https://ncbi.nlm.nih.gov/pubmed/24173670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0063-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky